Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 73 matching records.
73 results — page 1 of 4
- Level DLaboratory StudyEurope PMC
Combined Therapy with Pirfenidone, Metformin, and Mesenchymal Stem Cells Attenuates Bleomycin-Induced Pulmonary Fibrosis in Rats
Laboratory Study on Scar, Chronic Inflammation, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
Biomedicines - Level AMeta-analysisPubMed
Antifibrotic efficacy of adipose-derived mesenchymal stem cell-based therapeutic strategies in pre-clinical models of pulmonary fibrosis: A systematic review and meta-analysis.
Meta-analysis on Scar, published in Eur J Pharmacol (2026) — summary generated from the PubMed abstract.
- 2026
Eur J Pharmacol - Level CProspective StudyPubMed
Tracheal delivery of HO-1-modified human umbilical cord-derived mesenchymal stem cells treats pulmonary arterial hypertension by enhancing pulmonary antioxidant and anti-inflammatory responses.
Prospective Study on Chronic Inflammation, published in Transl Res (2026) — summary generated from the PubMed abstract.
- 2026
Transl Res - Level DLaboratory StudyPubMed
Ratio of miRNA-29 to miRNA-199 expression coordinates mesenchymal stem cell repair of bleomycin-induced pulmonary injury.
Laboratory Study, published in Mol Ther Nucleic Acids (2025) — summary generated from the PubMed abstract.
- 2025
Mol Ther Nucleic Acids - Level DAnimal StudyPubMed
Intravenous mesenchymal stem cell transplantation mitigates pulmonary vascular remodeling but poses dose related risks in a pulmonary veno-occlusive disease model.
Animal Study on Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther2 citations - Level DNarrative ReviewEurope PMC
A bibliometric analysis of research trends in mesenchymal stem cell therapy for neonatal bronchopulmonary dysplasia: 2004-2024
Narrative Review on Chronic Inflammation, Immune Modulation, published in Front Pediatr (2025) — summary generated from the PubMed abstract.
- 2025
Front Pediatr1 citations - Level DAnimal StudyPubMed
Combinational Therapy of Mesenchymal Stem Cells and Metformin in Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rat Model.
Animal Study on Chronic Inflammation, published in Appl Biochem Biotechnol (2025) — summary generated from the PubMed abstract.
- 2025
Appl Biochem Biotechnol - Level DAnimal StudyPubMed
Comparative study of adipose tissue derived mesenchymal stem cells with rapamycin on paraquat-induced acute lung injury and pulmonary fibrosis in a mouse model: histological and biochemical study.
Animal Study on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther2 citations - Level DAnimal StudyEurope PMC
Human umbilical cord mesenchymal stem cell-derived exosomes prevent and alleviate experimental pulmonary fibrosis by modulating the cytoskeleton of macrophages
Animal Study, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level DAnimal StudyEurope PMC
Glycogen engineering improves the starvation resistance of mesenchymal stem cells and their therapeutic efficacy in pulmonary fibrosis
Animal Study, published in Elife (2025) — summary generated from the PubMed abstract.
- 2025
Elife - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell therapy for pulmonary hypertension: an update
Narrative Review on Cardiovascular Disease, Chronic Inflammation, published in Front Bioeng Biotechnol (2025) — summary generated from the PubMed abstract.
- 2025
Front Bioeng Biotechnol - Level DAnimal StudyEurope PMC
EPO regulates the differentiation and homing of bone marrow mesenchymal stem cells through Notch1/Jagged pathway to treat pulmonary hypertension
Animal Study on Systemic / IV, published in Heliyon (2024) — summary generated from the PubMed abstract.
- 2024
Heliyon2 citations - Level DAnimal StudyPubMed
Pulmonary passage of canine adipose tissue-derived mesenchymal stem cells through intravenous transplantation in mouse model.
Animal Study on Hair & Scalp, Systemic / IV, published in J Vet Sci (2024) — summary generated from the PubMed abstract.
- 2024
J Vet Sci2 citations - Level DAnimal StudyPubMed
Mesenchymal stem/stromal cells alleviate early-stage pulmonary fibrosis in a uPAR-dependent manner.
Animal Study on Face & Skin, Systemic / IV, published in Cell Biol Int (2024) — summary generated from the PubMed abstract.
- 2024
Cell Biol Int - Level DAnimal StudyPubMed
Medication effects on pulmonary thromboembolism in mice intravenously transplanted with canine adipose tissue-derived mesenchymal stem cells.
Animal Study on Hair & Scalp, Systemic / IV, published in J Vet Sci (2024) — summary generated from the PubMed abstract.
- 2024
J Vet Sci - Level ASystematic ReviewPubMed
The Application of Mesenchymal Stem Cell Therapy in Treating Pulmonary Fibrosis: A Scoping Review.
Systematic Review on Scar, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus1 citations - Level CProspective StudyPubMed
Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients.
Prospective Study, published in Cells (2024) — summary generated from the PubMed abstract.
- 2024
Cells3 citations - Level DAnimal StudyPubMed
Reversal of Pulmonary Fibrosis: Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly versus Human-Adipose-Derived Mesenchymal Stem Cells.
Animal Study, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci11 citations - Level CProspective StudyEurope PMC
Mesenchymal stem cells and pulmonary fibrosis: a bibliometric and visualization analysis of literature published between 2002 and 2021
Prospective Study with a reported sample of 64 on Hip, Systemic / IV, published in Front Pharmacol (2023) — summary generated from the PubMed abstract.
- 2023
- n = 64
Front Pharmacol11 citations - Level DAnimal StudyPubMed
Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
Animal Study, published in Sci Rep (2023) — summary generated from the PubMed abstract.
- 2023
Sci Rep31 citations - Level DNarrative ReviewEurope PMC
Boosting therapeutic efficacy of mesenchymal stem cells in pulmonary fibrosis: The role of genetic modification and preconditioning strategies
Narrative Review on Scar, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Iran J Basic Med Sci (2023) — summary generated from the PubMed abstract.
- 2023
Iran J Basic Med Sci5 citations - Level CProspective StudyPubMed
Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients.
Prospective Study on Scar, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther - Level BClinical TrialEurope PMC
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
Clinical Trial on Face & Skin, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther22 citations - Level CProspective StudyPubMed
[Effects of exosomes from human adipose-derived mesenchymal stem cells on pulmonary vascular endothelial cells injury in septic mice and its mechanism].
Prospective Study with a reported sample of 3 on Scar, published in Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi (2022) — summary generated from the PubMed abstract.
- 2022
- n = 3
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi6 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406